Home Zydus Explores Newer Treatment Options With Its Breakthrough Drug, Lipaglyn
 

Keywords :   


Zydus Explores Newer Treatment Options With Its Breakthrough Drug, Lipaglyn

2014-06-04 12:25:12| drugdiscoveryonline Home Page

Exploring newer therapeutic usage of its breakthrough drug Lipaglyn™ (Saroglitazar), the Zydus Group has now initiated Phase III trials of the molecule for patients suffering from lipodystrophy

Tags: options treatment drug newer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.11Atlantic Tropical Weather Outlook
01.11Eastern North Pacific Tropical Weather Outlook
01.11Boeing makes 38% pay rise offer in bid to end strike
01.11The house paints that promise much more than colour
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11Technology adoption: What's on the ag tech horizon for 2025
01.11Technology adoption: What's on the ag tech horizon for 2025
More »